Sarepta Therapeutics, Inc. (SRPT)
16.32
-0.44
(-2.63%)
USD |
NASDAQ |
Mar 02, 16:00
15.99
-0.33
(-2.02%)
After-Hours: 07:46
Sarepta Therapeutics Research and Development Expense (Annual) : 1.496B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| REGENXBIO, Inc. | 192.31M |
| Keros Therapeutics, Inc. | 173.63M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |